IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) (Q34988311)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) |
scientific article |
Statements
1 reference
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) (English)
1 reference
Alastair Compston
1 reference
Joanne L Jones
1 reference
Chia-Ling Phuah
1 reference
Amanda L Cox
1 reference
Sara A Thompson
1 reference
Maria Ban
1 reference
Jacqueline Shawcross
1 reference
Amie Walton
1 reference
Stephen J Sawcer
1 reference
Alasdair J Coles
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference